Save time and get answers to complex questions with AI chat
When will latisse patent expire?What excipients are combined with ruxolitinib in apotex's medication?Drugpatentwatch trametinib?Guselkumab loss of exclusitivy?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for repatha
Repatha (evolocumab) is made by Amgen, the U.S. company that develops and sells the medicine. [1]
Repatha is part of the PCSK9 inhibitor class. Other drugs in the same class include Praluent (alirocumab), which is made by Sanofi and Regeneron. [2]
For the original brand product, Repatha is marketed by Amgen. Biosimilars are not applicable to this medicine because evolocumab is a monoclonal antibody; instead, PCSK9 inhibitors generally face competition through other branded drugs in the class (like Praluent), not biosimilar “Repatha” equivalents. [1][2] Sources: [1] https://www.drugs.com/repatha.html [2] https://www.drugs.com/condition/high-cholesterol.html
Other Questions About Repatha :